最新の財務諸表(Form-10K)によると、Tenon Medical Incの総資産は$9で、純損失は$-13です。
TNONの主要な財務比率は何ですか?
Tenon Medical Incの流動比率は3、純利益率は-433.33、1株当たり売上高は$2.47です。
Tenon Medical Incの収益はセグメントまたは地域別にどのように分けられていますか?
Tenon Medical Inc の最大収益セグメントは Surgical Implant-system で、最新の利益発表における収益は 2,928,000 です。地域別に見ると、United States が Tenon Medical Inc の主要市場であり、収益は 2,928,000 です。
Tenon Medical Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Tenon Medical Incの純損失は$-13です。
Tenon Medical Incに負債はありますか?
はい、Tenon Medical Incの負債は3です。
Tenon Medical Incの発行済株式数は何株ですか?
Tenon Medical Incの総発行済株式数は3.13株です。
主要データ
前終値
$0.7938
始値
$0.7801
当日レンジ
$0.7789 - $0.8082
52週レンジ
$0.641 - $5.85
取引高
54.5K
平均取引高
1.0M
配当利回り
--
1株当たり利益(TTM)
-2.76
時価総額
$8.4M
TNONとは何ですか?
Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company is headquartered in Los Gatos, California and currently employs 27 full-time employees. The company went IPO on 2022-04-27. The firm has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant.